The Metabolomics of Parkinson’s Disease
Global metabolomics, when applied to Parkinson’s Disease research, has the potential to make a significant impact in biomarker development, whether for susceptibility, diagnosis, pharmacodynamic response or prognostic assessment of disease. And even beyond biomarkers, Next- Generation Metabolomics from Panome Bio opens doors to understanding molecular mechanisms and signaling pathways involved in PD.
